S. J. Antonia Et Al. , "PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer," 59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO) , vol.99, California, United States Of America, pp.1314-1315, 2017
Antonia, S. J. Et Al. 2017. PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer. 59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO) , (California, United States Of America), 1314-1315.
Antonia, S. J., Villegas, A., Daniel, D., Baz, D. V., Murakami, S., Hui, R., ... Yokoi, T.(2017). PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer . 59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO) (pp.1314-1315). California, United States Of America
Antonia, S. Et Al. "PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer," 59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO), California, United States Of America, 2017
Antonia, S. J. Et Al. "PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer." 59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO) , California, United States Of America, pp.1314-1315, 2017
Antonia, S. J. Et Al. (2017) . "PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer." 59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO) , California, United States Of America, pp.1314-1315.
@conferencepaper{conferencepaper, author={S. J. Antonia Et Al. }, title={PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer}, congress name={59th Annual Meeting of the American-Society-for-Therapeutic-Radiation-Oncology (ASTRO)}, city={California}, country={United States Of America}, year={2017}, pages={1314-1315} }